Stockert 3T Heater-Cooler Lawyers For Wrongful Death LawsuitsStockert 3T Heater-Cooler System lawyers are filing failure to warn lawsuits due to increased risk of infections caused by the Cooler Systems during cardio thoracic surgery.
Stockert 3T Lawsuits FiledLawsuits are being filed against LivaNova PLC for their 3T heating-cooling system. This system has been found to transmit bacteria into patients during open-chest cardiac surgery. The nontuberculous mycobacteria causes Mycobacterium chimaera which can result in death,
What is The 3T Heater-Cooler System?The 3T heater-cooler units are used during surgery to control body temperature. They have water tanks that move temperature-controlled water to heat exchangers or blankets, which cool or warm the recipients body.
3T Heater-Cooler System IssuesThe water in the 3T systems can become contaminated resulting in bacteria being released into the air through the device’s exhaust vent. This bacteria can infect a patient. It can take several years between the time a patient is exposed to the bacteria and an infection is diagnosed.
Have You Had Surgery Using A 3T Cooler Device?
Up To 4 Years After Surgery Look for signs:
- surgical site infection,
- abscess, bacteremia,
- renal insufficiency,
- fever of undetermined origin,
- night sweats,
- joint pain,
- weight loss,
Contact our Stocker 3T Lawyers
Complications From A Hernia Mesh Repair?
Has the Hernia Returned?Patients are having complications from the Ethicon defective recalled hernia mesh. Hernia mesh lawyers are accepting lawsuits. The U.S. Judicial Panel on Multidistrict Litigation (JPML) is scheduled to hear oral arguments about consolidating federally filed lawsuits involving Atrium Medical Corp.’s C-Qur line of polypropylene surgical mesh for hernia repair. Hernia mesh lawyers expect that an MDL for Ethicon’s Physiomesh will be formed soon given the number of cases coming forth.
Florida Physiomesh Lawsuit FiledThere has been a Florida lawsuit filed on December 27, 2016 in the U.S. District Court, Middle District of Florida for complications associated with the defective mesh. It was necessary for this woman to go thru additional hernia revision surgery. An abdominal bulge, recurrent hernia, pain, and adhesion was suffered Her lawsuit claims that the Physiomesh Composite mesh patch for her hernia surgery was not reasonably safe. The risks of the design outweighed any potential benefits. (Case No. 8:16-cv-03502-JDW-JSS)
Hernia Mesh Lawyers Are Filing Lawsuits
There has been a need for revision surgery due to:
- Severe Abdominal Pain
- Organ Perforation, Adhesions or Erosion
Surgical Removal of Hernia Mesh Lawsuits
Power Morcellator Lawyers Filing Lawsuits
Power Morcellator Device Spreads Uterine Cancer Continue To GrowMorcellator lawyers advise that power Morcellator lawsuits have been consolidated by the Judicial Panel on Multidistrict Litigation. 2652 cases have been filed for women who underwent laparoscopic power morcellation for hysterectomies or myomectomies and were put at risk for spreading previously hidden cancer cells. The Facts
- The Morcellator has jaw-like blades that rapidly spin to shred fibroid tissue so that the pieces are able to be removed from the body.
- It is now known that as tool does this, it uncovers and disseminates uterine sarcoma cells.
- The FDA issued a safety warning against laparoscopic power morcellation procedures due to the risk of spreading cancer.
- Many women have developed serious or fatal leiomyosarcoma.
- There have been deaths of “hundreds, if not thousands of women in America”.
Hemorrhages Caused by Xarelto
Xarelto Lawyers Filing Extensive Bleeding LawsuitsOur Xarelto lawyers are accepting Xarelto lawsuits for hemorrhage caused by Xarelto. Nationwide Xarelto attorneys are reviewing cases of excessive bleeding from Xarelto. In a recent Xareleto lawsuit a widow from Missouri has filed an Xarelto claim against Johnson & Johnson, Janssen Research & Development, Bayer Healthcare Pharmaceuticals, et al. to demand that the defendants be held liable for the death of her husband. Dixie A. Smith, surviving spouse of Jay Christopher Smith, filed the complaint in the U.S. District Court for the Eastern District of Louisiana, where it joins similar lawsuits pending in multidistrict litigation (MDL) No. 2592 before Judge Fallon. The plaintiff contends that had her late husband never taken the defendants’ medication, Xarelto, he would not have suffered a deadly intracerebral hemorrhage. Ms. Smith is suing for compensatory damages for past, present, and future economic expenditures incurred as a result of the decedent’s use of Xarelto, including medical and funeral expenses, loss of earnings, loss of companionship and support, and loss of the prospective net accumulations of an estate. Xarelto Caused A Brain Hemorrhage The decedent’s physician prescribed Xarelto (rivaroxaban) during December of 2012. He continued to take the medication as prescribed until May of 2013. On May 4, the decedent was admitted to an intensive care unit (ICU), at which point the hospital staff discontinued his use of Xarelto. He was transferred to the care of a specialty hospital unit on May 18 and on May 22 he died of the intracerebral hemorrhage. According to Ms. Smith’s Xarelto lawsuit, her late husband’s passing was a direct result of his use of rivaroxaban, which he reportedly never would have taken had he been fully informed of the risks. Xarelto is an anticoagulant or blood thinner that is prescribed for the treatment and prevention of blood clots. The medication is intended to reduce the risk of life-threatening complications caused by blood clots, including pulmonary embolism and stroke. Xarelto Lawsuits The product liability lawsuit regarding Xarelto draws attention to several reviews and clinical studies of the drug, including a 2012 report issued by The Institute for Safe Medication Practices. This report stated that there had been “356 reports of serious, disabling, or fatal injury in which rivaroxaban was the primary suspect drug. The report more than doubled from the previous quarter total of 128 cases.” The organization brought these statistics to the attention of the defendants, who reportedly advised The Institute for Safe Medication Practices that the data did not reflect any safety issues that required action. Ms. Smith’s Xarelto lawsuit alleges that the defendants prioritized profit over patient safety. Her complaint further claims that the defendants concealed their knowledge of the severe and life-threatening complications of Xarelto from consumers and the medical community. The lawsuit notes that the pharmaceutical giants failed to highlight the risks of uncontrollable bleeding events, nor did they provide medical protocols for stabilizing patients suffering from these bleeding events. Xarelto had been marketed as a replacement for an older blood thinner, warfarin (Coumadin). Warfarin has been used for years for patients who may be at a higher risk of blood clots. However, patients taking warfarin required regular medical monitoring and dietary restrictions, which Xarelto had promised to eliminate. Our Xarelto lawyers have been reviewing claims for excessive bleeding like these. Xarelto lawsuits are now consolidated in an MDL because many people have suffered injuries of a same type from Xarelto. Speak to an Xarelto lawyer today.
NexGen Knee Replacement Lawyers For Failure And Complications
What Are The Complications of Zimmer NexGen Knee Replacements?
Early failure and replacement of the device
Loosening of artificial knee
Knee or joint pain
Popping, Fracture, Dislocation
Difficulty walking or standing
Defective Knee Replacement Attorney For Filing In The NexGen MDL Class Action
MIS Tibial Components and the NexGen LPS-Flex GSF Femoral Component lawsuits, have been consolidated in the U.S. District Court of Northern Illinois under the multidistrict litigation (MDL) case number 2272. Zimmer Manufacturing has recalled the NexGen MIS Tibial Component due to to one or more complications.
Devices In The NexGen MDL Class Action:
All NexGen MIS Total Knee Procedure Stemmed Tibial Components
NexGen Complete Knee Solution Cruciate Retaining-Flex Femoral Components (CR-Flex)
NexGen Complete Knee Solution Gender Solutions Female LPS-Flex (GSF LPS-Flex)
NexGen Complete Knee Solution Legacy Posterior Stabilized-Flex Femoral Components (LPS-Flex)
NexGen Complete Knee Solution CR-Flex Gender Solutions Female CR-Flex (GSF-Flex)
If you have a Zimmer NexGen knee replacement and are experiencing complications your doctor immediately to evaluate if the device is working properly. You may need revision surgery. Speak to one of our NexGen knee replacement lawyers.
South Florida Metronic Infuse Bone Graft Lawyers Filing Bone Graft Lawsuits
Have you been injured by the Metronic Infuse Bone Graft Off Label Use?
Severe Complications Of The Bone Graft Given the proximity of the cervical spine to the airway passage
- Difficulty Breathing, Swallowing or Speaking
- Compression of the Airway
- Respiratory Depression
- Nerve Damage
- Bone Loss
- Unwanted Bone Growth
- Male Sterility
If you or a loved one has been injured by the Metronic Infuse Bone Graft In
Miami, Fort Lauderdale, Hollywood, Deerfield Beach, Pompano Beach, Boca Raton, Delray Beach, West Palm Beach, Stuart , Ft Myers or nationwide
Call and speak to one of our qualified infuse bone graft class action lawyers today.
Actos is a medication taken by Type II ( adult onset ) diabetics to control their insulin production. Actos lawsuits are being filed for victims of bladder cancer from Actos.
Actos Lawsuit Update
Actos lawsuits that allege long-term use of the Type 2 diabetes drug caused patients to develop bladder cancer continue to move forward in a multidistrict litigation underway in U.S. District Court, Western District of Louisiana. According to court documents, the proceeding’s next Case Management Conference will be held on Thursday, October 24, 2013, at 10:30 a.m. (In re: Actos Product Liability Litigation, MDL No. 2299)
Actos Lawsuit News
According to court documents Actos litigation involving bladder cancer allegations got underway shortly after the U.S. Food & Drug Administration (FDA) warned in June 2011 that use of the drug for 12 months or more had been associated with an increased risk of the disease. At that time, the FDA ordered Takeda Pharmaceuticals to add new warnings to the Actos label about its potential to cause bladder cancer.
Court filings indicate that more than 2,500 Actos lawsuits are now pending in the Western District of Louisiana, where the first case will go to trial in January. Plaintiffs in Actos lawsuits allege that Takeda Pharmaceuticals and other defendants concealed knowledge that the medication could increase a person’s chances of developing bladder cancer, and failed to provide adequate warnings about that risk to the public and medical community.
On the state level, two Actos claims involving bladder cancer allegations have already gone to trial. Last month, a Maryland State Court jury awarded $1.7 million to the family of a man who died of bladder cancer following long-term use of Actos. However, according to court records, the judge presiding over the trial tossed out the verdict because the jury also found that the decedent’s decades-long smoking habit contributed to the development of the disease. (An v. Nieberlein, 24-C12003565, Circuit Court for the City of Baltimore, State of Maryland.)
This past April, a Los Angeles Superior Court jury awarded $6.5 million to a plaintiff who developed bladder cancer following four years of Actos use. However, the plaintiff is currently appealing a decision by the judge overseeing the case to grant Takeda Pharmaceuticals’ request to set aside the verdict. (Cooper v. Takeda Pharmaceuticals America Inc., CGC-12-518535, California Superior Court)
Long-term users of Actos ( over 2 years ) who have been diagnosed with bladder cancer may be eligible to file an Actos lawsuit against Takeda Pharmaceuticals.
Actos Lawsuit Criteria
1. You must have taken Actos for over two years
2. You must have a confirmed diagnosis of bladder cancer
3. You must have no prior medical history of baldder cancer prior to taking Actos
Pradaxa Lawsuit News and Updates
The Pradaxa lawsuits are moving forward. The Pradaxa lawyers advise all victims and families of extensive bleeding from Pradaxa to file their Pradaxa lawsuit by callingour Pradaxa hotline rigjht away. The Pradaxa lawsuits are being filed in MDL 2385 – Pradaxa (Dabigatran Etexilate) Products Liability Litigation. Over 650 lawsuits have been filed in the Pradaxa MDL (No. 2385, U.S. District Court, Southern District of Illinois).
Pradaxa is an anticoagulant medication prescribed to people with heart problems. But, Pradaxa has no antidote and extensive bleeding or death has been the result in many instances.Pradaxa causes life-threatening internal bleeding.
Side effects of Pradaxa may include:
- Brain hemorrhage
- Digestive system bleeding
- Uncontolled internal bleeding
The Pradaxa lawsuits have been mounting up quickly. Many victims are seniors who fall and end up with a brain bleed internal bleeding or bleeding that does not stop and cannot be controlled by any other medication. Anyone who cares for or has a love do one who is on Pradaxa must observe them carefully.
Signs Of Externsive Bleeding
- a sudden severe headache
- seizures with no previous history of seizures
- weakness in an arm or leg
- nausea or vomiting
- decreased alertness; lethargy
- changes in vision
- tingling or numbness
- difficulty speaking or understanding speech
- difficulty swallowing
- difficulty writing or reading
- loss of fine motor skills, such as hand tremors
- loss of coordination
- loss of balance
- an abnormal sense of taste
- loss of consciousness
Extensive Bleeding From Pradaxa can be fatal. If you have lost a loved one due to extensive bleeding from Pradaxa call for a Pradaxa lawyer today.
Risperdal Lawyers Filing Gynecomastia Lawsuits
If you or a loved one was prescribed Risperdal as a teenage boy and now have enlarged breasts, developed female type breasts and /or been diagnosed with Gynecomastia, contact Class Action Lawyer Network Risperdal Injury Lawyers today to discuss your options in a Risperdal lawsuit.
Our Resperdal lawyers are reviewing cases for young boys diagnosed with gynecomastia or male breasts after using Risperdal. Problems may result in:
- Breast Growth Among Boys
- Puffy Nipples or Enlarged Nipples
- Galactorrhea (production of milk from breasts)
- Painful Breasts or Nipple Discharge
- Mastectomy or Gynecomastia Surgery to Remove Male Breasts
- Gynecomastia (growth of male breasts, which may be painful or tender)
If your son has been diagnosed with Gynacomastia call our Resperdal helpline and speak to our trained medical social worker today.
Rispedral Side Effects In Male Children
Risperdal (risperidone) is an antipsychotic manufactured by Johnson & Johnson. It was originally approved by the FDA for use for adults with schizophrenia. Risperdal has also been widely used by children for bi-polar disorders, autism, irritability, aggression and behavior disorders.
Speak To A Risperdal Lawyer
The Riserdal lawyers are reviewing cases for Risperdal breast growth among boys.
Children Are Being Injured By Risperdal
Lawsuits are being filed for abnormal development of large mammary glands among boys and adolescents, resulting in breast development. Surgery has been necessary to remove the breasts caused by the Risperdal gynecomastia. This has caused emotional trauma for boys and young adult males and some incidents of suicide. Parents throughout the United States are pursuing a Rispedal lawsuit on behalf of kchildren who developed breasts on Risperdal.
Lawsuits allege that Johnson & Johnson failed to adequately research the effects of their medication or warn about the connection between Risperdal and breast growth.
Risperdal Lawsuit Update
Although Resperdal is not currently an MDL, settlements for Risperdal breast growth have been reached by Johnson & Johnson in lawsuits bellwether trials where a number of cases are presented to juries to test the potential settlements and outcomes. Do not delay. Call no to discuss a Resperdal lawsuit.